KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 78 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,889,500 | +106900.0% | 1,650,000 | 0.0% | 0.85% | +22.8% |
| Q2 2023 | $14,850 | +14.5% | 1,650,000 | 0.0% | 0.69% | +8.2% |
| Q1 2023 | $12,969 | -99.6% | 1,650,000 | +725.0% | 0.64% | +216.9% |
| Q4 2019 | $3,562,000 | +53.5% | 200,000 | 0.0% | 0.20% | +19.6% |
| Q3 2019 | $2,320,000 | -47.6% | 200,000 | 0.0% | 0.17% | -55.9% |
| Q2 2019 | $4,430,000 | -22.6% | 200,000 | 0.0% | 0.38% | -42.4% |
| Q1 2019 | $5,724,000 | +44.9% | 200,000 | 0.0% | 0.66% | +35.7% |
| Q4 2018 | $3,950,000 | -10.7% | 200,000 | 0.0% | 0.49% | -0.6% |
| Q3 2018 | $4,422,000 | – | 200,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |